Genscript Biotech Corporation (HKG:1548)
Hong Kong
· Delayed Price · Currency is HKD 15.06
-0.14 (-0.92%)
At close: Dec 5, 2025
Genscript Biotech Ratios and Metrics
Market cap in millions HKD. Fiscal year is January - December.
Millions HKD. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 4, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Market Capitalization | 32,924 | 21,097 | 42,166 | 52,563 | 72,496 | 22,033 | Upgrade
|
| Market Cap Growth | 42.92% | -49.97% | -19.78% | -27.50% | 229.03% | -33.64% | Upgrade
|
| Enterprise Value | 29,906 | 18,906 | 38,022 | 47,670 | 64,744 | 14,836 | Upgrade
|
| Last Close Price | 15.06 | 9.84 | 19.86 | 24.85 | 34.50 | 11.28 | Upgrade
|
| PE Ratio | 1.35 | 0.92 | - | - | - | - | Upgrade
|
| Forward PE | 54.19 | - | - | - | - | - | Upgrade
|
| PS Ratio | 5.06 | 4.57 | 9.63 | 10.77 | 18.97 | 7.27 | Upgrade
|
| PB Ratio | 0.95 | 0.63 | 2.64 | 4.95 | 6.70 | 3.48 | Upgrade
|
| P/TBV Ratio | 0.95 | 0.63 | 3.94 | 6.85 | 9.25 | 3.30 | Upgrade
|
| P/FCF Ratio | 32.67 | - | - | - | - | - | Upgrade
|
| P/OCF Ratio | 18.36 | 35.90 | - | - | - | - | Upgrade
|
| PEG Ratio | - | 2.52 | 2.52 | 2.52 | 2.52 | 2.52 | Upgrade
|
| EV/Sales Ratio | 4.60 | 4.09 | 8.68 | 9.77 | 16.94 | 4.90 | Upgrade
|
| EV/EBITDA Ratio | 205.72 | 34.75 | 58.29 | - | - | - | Upgrade
|
| EV/EBIT Ratio | - | 262.23 | 185.81 | - | - | - | Upgrade
|
| EV/FCF Ratio | 29.68 | - | - | - | - | - | Upgrade
|
| Debt / Equity Ratio | 0.12 | 0.17 | 0.41 | 0.48 | 0.30 | 0.07 | Upgrade
|
| Debt / EBITDA Ratio | 2.20 | 8.51 | 8.59 | - | - | - | Upgrade
|
| Debt / FCF Ratio | 4.27 | - | - | - | - | - | Upgrade
|
| Asset Turnover | 0.19 | 0.14 | 0.19 | 0.26 | 0.27 | 0.34 | Upgrade
|
| Inventory Turnover | 8.23 | 7.64 | 5.12 | 6.17 | 5.46 | 5.60 | Upgrade
|
| Quick Ratio | 1.78 | 2.46 | 4.50 | 2.99 | 3.80 | 2.85 | Upgrade
|
| Current Ratio | 1.96 | 2.72 | 4.76 | 3.23 | 3.97 | 3.03 | Upgrade
|
| Return on Equity (ROE) | -1.94% | -5.46% | 9.56% | -31.12% | -47.05% | -47.38% | Upgrade
|
| Return on Assets (ROA) | 2.56% | 0.13% | 0.55% | -11.45% | -12.88% | -10.94% | Upgrade
|
| Return on Capital (ROIC) | 2.88% | 0.15% | 0.67% | -14.32% | -17.72% | -20.18% | Upgrade
|
| Return on Capital Employed (ROCE) | 3.70% | 0.20% | 0.90% | -21.90% | -20.80% | -18.30% | Upgrade
|
| Earnings Yield | 74.19% | 109.05% | -1.77% | -3.36% | -3.86% | -7.21% | Upgrade
|
| FCF Yield | 3.06% | -4.42% | -9.99% | -4.99% | -2.90% | -9.61% | Upgrade
|
| Buyback Yield / Dilution | -4.08% | -3.27% | -0.58% | -3.28% | -6.83% | -2.53% | Upgrade
|
| Total Shareholder Return | -4.08% | -3.27% | -0.58% | -3.28% | -6.83% | -2.53% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.